Anne Vincent-Salomon

发表

Re: HER2 testing in the real world (multiple letters) [1]

Edith A. Perez, Anne Vincent-Salomon, Gaëtan MacGrogan, 2003 .

ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing

François-Clément Bidard, Anne Vincent-Salomon, Alexandre Eeckhoutte, 2020, Bioinform..

Corrigendum: Signatures of mutational processes in human cancer

Roland Eils, Natalie Jäger, Adam P. Butler, 2013, Nature.

Molecular profiling of patient-derived breast cancer xenografts

Anne Vincent-Salomon, Olivier Delattre, David Gentien, 2012, Breast Cancer Research.

Processed pseudogenes acquired somatically during cancer development

Andrew Menzies, Adam P. Butler, Jon W. Teague, 2014, Nature Communications.

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.

Inna Kuperstein, Andrei Zinovyev, Anne Vincent-Salomon, 2018, Cancer cell.

A prognostic DNA signature for T1T2 node‐negative breast cancer patients

Anne Vincent-Salomon, Bernard Asselain, Olivier Delattre, 2010, Genes, chromosomes & cancer.

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Emmanuel Barillot, Anne Vincent-Salomon, Guillem Rigaill, 2013, PloS one.

Unraveling the Role of Huntingtin in Breast Cancer Metastasis.

Anne Vincent-Salomon, A. Vincent-Salomon, S. Vacher, 2015, Journal of the National Cancer Institute.

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma

Roman Rouzier, Anne Vincent-Salomon, Fabien Reyal, 2011, PloS one.

High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study.

Anne Vincent-Salomon, Magali Lacroix-Triki, Marie-Christine Mathieu, 2006, European journal of cancer.

Epithelial–mesenchymal transition in breast cancer development

Anne Vincent-Salomon, Jean Paul Thiery, J. Thiery, 2003 .

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.

Emmanuel Barillot, Anne Vincent-Salomon, Guillem Rigaill, 2013, Cancer research.

High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.

Olivier Lantz, Anne Vincent-Salomon, Thierry Dorval, 2014, Cancer research.

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance

Anne Vincent-Salomon, Valérie Choesmel, J. Thiery, 2004, Breast Cancer Research.

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

Emmanuel Barillot, Philippe Hupé, Anne Vincent-Salomon, 2008, Breast Cancer Research.

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2016, Genome research.

The circular RNome of primary breast cancer

Alain Viari, Johan Staaf, Carlos Caldas, 2019, Genome research.

ESR1 gene amplification in breast cancer: a common phenomenon?

Anne Vincent-Salomon, Olivier Delattre, Virginie Raynal, 2008, Nature Genetics.

Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

Anne Vincent-Salomon, Patricia de Cremoux, A. Vincent-Salomon, 2008, Clinical Cancer Research.

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

Bin Tean Teh, Andrew Menzies, Keiran Raine, 2014, eLife.

Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas

Roman Rouzier, Anne Vincent-Salomon, Guillem Rigaill, 2013, PloS one.

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Nicolas Servant, Anne Vincent-Salomon, Xavier Paoletti, 2015, The Lancet. Oncology.

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

Carlos Caldas, Fengtang Yang, Rosalind Eeles, 2015, Genome research.

Correction to: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature, (2016), 534, 7605, (47-54), 10.1038/nature17676)

Ville Mustonen, Sung-Min Ahn, Stefania Tommasi, 2019 .

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

Anne Vincent-Salomon, Salvatore Piscuoglio, Magali Lacroix-Triki, 2015, Genome Biology.

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

Alain Viari, Thomas Bachelot, Michael R. Stratton, 2016, Nature Communications.

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

Andrew Menzies, Adam P. Butler, Jon W. Teague, 2014, Science.

Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

Anne Vincent-Salomon, Patricia de Cremoux, J. Thiery, 2004, Clinical Cancer Research.

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

Roman Rouzier, Etienne Rouleau, Nicolas Servant, 2015, Journal of the National Cancer Institute.

HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

Philippe Broët, Anne Vincent-Salomon, Jérôme Couturier, 2007, PloS one.